- Samsung’s latest Watch received FDA clearance for its EKG-tracking capability.
- Samsung’s move to obtain FDA clearance for its Watch3’s EKG feature suggests that it may be following Apple’s lead and placing a greater emphasis on its smartwatch’s healthcare features.
- Insider Intelligence publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here.
Electronics giant Samsung announced that its EKG-tracking app — which is linked to its Galaxy Watch3 — landed FDA clearance. Its Watch3 will also contain built-in sensors to monitor blood pressure and blood oxygen saturation.
Samsung is taking a page from Apple’s book and revving up its Watch’s health-focused features to make it a valuable healthcare tool for consumers. For context, Apple recently announced new features that will improve its Watch’s health-focused capabilities, including a sleep-tracking feature to monitor sleeping habits. In June, the tech giant expanded the Apple Watch’s ability to send EKG recordings to physicians, which can be automatically added to a patients’ EHR in Epic.
Now, Samsung’s latest move to obtain FDA clearance for its Watch3’s EKG feature suggests that it’s following suit and placing a greater emphasis on its smartwatch’s healthcare features. This wouldn’t be the Samsung Watch’s first foray into healthcare: Last year, it revealed a blood pressure tracking functionality that can be integrated with an app. We don’t think it would be hard to imagine Samsung tacking on additional remote cardiac monitoring capabilities with future Watch updates, which will likely help boost its clinical validity for research partnerships. For example, we saw Apple leverage its Apple Watch 4’s heart monitoring tech to detect Atrial Fibrillation (AFib) last year when it scored a tie-up with Johnson & Johnson to curtail the risk of stroke in seniors.
The pandemic has led more consumers to try health tech like wearables for the first time — and we expect to see heightened competition between Apple and Samsung as a result. The coronavirus and stay-at-home orders have US individuals increasingly leaning on digital health tech: A Mojo Vision survey indicates that 60% of US first adopters said the pandemic lead them to try out new devices or apps for the first time — and 76% of this audience noted that they’ll likely continue purchasing this tech once outbreaks subside. This presents a significant opportunity for wearable giants like Apple and Samsung to expand their health-focused Watch features, considering they both hold massive consumer bases in the US.
Apple continues to dominate the smartwatch space, possessing 55% of the market as of Q1 2020, while Samsung comes in a far second. However, Samsung’s FDA-cleared EKG-tracking feature suggests the company recognizes the increased demand for digital health tech amid the pandemic — and if it continues to build out its features, we think it could pose a threat to Apple’s No. 1 spot. We expect to see Apple and Samsung increasingly improve their health-focused features to fend off competition and hook in new users, considering that consumers won’t likely lose interest in digital health wearables as coronavirus cases continue to rise in the US.
Want to read more stories like this one? Here’s how you can gain access:
- Join other Insider Intelligence clients who receive this Briefing, along with other Digital Health forecasts, briefings, charts, and research reports to their inboxes each day. >> Become a Client
- Explore related topics more in depth. >> Browse Our Coverage
Are you a current Insider Intelligence client? Log in here.
Real Life. Real News. Real Voices
Help us tell more of the stories that matterBecome a founding member
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe